Revvity | PKI - Cost Of Sales


Revvity reported $323.46M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Agilent USD 845M 7M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Bio-Rad Laboratories USD 348M 38.4M Dec/2025
Bruker USD 443.6M 84.4M Mar/2026
Celltrion KRW 92.83B 14.59B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 12.39B 1.76B Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Illumina USD 370M 30M Mar/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Laboratory Of America USD 2.6B 4.2M Mar/2026
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Organigram Holdings CAD 43.39M 13.54M Mar/2026
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Pharma Mar EUR 3.66M 116K Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Quidel USD -79.5M 528.3M Mar/2026
Repligen USD 85.97M 8.11M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Sartorius EUR 484.6M 46.6M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
Waters USD 725M 350.06M Mar/2026
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026